Morphological and functional differentiation in BE(2)-M17 human neuroblastoma cells by treatment with Trans-retinoic acid
- Devon Andres†1,
- Brian M Keyser†1,
- John Petrali1,
- Betty Benton1,
- Kyle S Hubbard1,
- Patrick M McNutt1 and
- Radharaman Ray1Email author
© Andres et al.; licensee BioMed Central Ltd. 2013
Received: 15 November 2012
Accepted: 9 April 2013
Published: 18 April 2013
Immortalized neuronal cell lines can be induced to differentiate into more mature neurons by adding specific compounds or growth factors to the culture medium. This property makes neuronal cell lines attractive as in vitro cell models to study neuronal functions and neurotoxicity. The clonal human neuroblastoma BE(2)-M17 cell line is known to differentiate into a more prominent neuronal cell type by treatment with trans-retinoic acid. However, there is a lack of information on the morphological and functional aspects of these differentiated cells.
We studied the effects of trans-retinoic acid treatment on (a) some differentiation marker proteins, (b) types of voltage-gated calcium (Ca2+) channels and (c) Ca2+-dependent neurotransmitter ([3H] glycine) release in cultured BE(2)-M17 cells. Cells treated with 10 μM trans-retinoic acid (RA) for 72 hrs exhibited marked changes in morphology to include neurite extensions; presence of P/Q, N and T-type voltage-gated Ca2+ channels; and expression of neuron specific enolase (NSE), synaptosomal-associated protein 25 (SNAP-25), nicotinic acetylcholine receptor α7 (nAChR-α7) and other neuronal markers. Moreover, retinoic acid treated cells had a significant increase in evoked Ca2+-dependent neurotransmitter release capacity. In toxicity studies of the toxic gas, phosgene (CG), that differentiation of M17 cells with RA was required to see the changes in intracellular free Ca2+ concentrations following exposure to CG.
Taken together, retinoic acid treated cells had improved morphological features as well as neuronal characteristics and functions; thus, these retinoic acid differentiated BE(2)-M17 cells may serve as a better neuronal model to study neurobiology and/or neurotoxicity.
KeywordsNeurons M17 Neurotoxicity Cell maturation Differentiation Retinoic acid Neuroexocytosis Voltage-gated calcium channels
Neurotoxic chemicals, such as lead (Pb) and organophosphorus (OP) insecticides are prevalent in the environment. The use of different in vitro cell culture assays for predicting the in vivo effects of these chemicals have been extensively reviewed in recent years and the issues pertaining to their use have also been discussed [1–5]. The in vitro systems have been developed and utilized not only to understand the mechanisms of toxicity at the molecular and cellular levels but also to screen potential neurotoxicants. Potentially toxic compounds would be candidates for in vivo testing. The objective of neurotoxicologic studies on cells and tissues in vitro is to characterize the cellular and molecular substrates and pathways that contribute to impaired behavior, altered function, or pathological changes in the whole animal following exposure to a toxicant . The two main types of cell culture systems used for in vitro neurological testing are (a) primary neuronal cell cultures dissociated from peripheral or central nervous system tissues and (b) clonal cell lines derived from tumors of neurological origin .
Primary neuronal cultures retain morphological, neurochemical, and electrophysiological properties of neurons in situ. However, long-term culturing of primary neurons has been a major challenge. This creates difficulties in addressing the fundamental questions concerning cellular and molecular interactions among the many functionally distinct neuronal cell types that contribute to the development and functioning of the mammalian central nervous system . Neuroblastoma cell lines have been used extensively as in vitro models for studies on neuronal development, neurological diseases and disorders as well as mechanisms of actions and neurotoxicity of compounds affecting the nervous system [2, 7, 8]. These in vitro models can provide a well-controlled system in which to study many of the critical cellular processes of neuronal development including proliferation, differentiation, growth, and synaptogenesis. Furthermore, cultured cell lines allow subtle changes in cell number, morphology, and functions to be readily detected compared to in vivo approaches and provide reproducibility in test results as well as providing a reduction in time, cost, and animal use [2, 7].
Neuroblastoma cells can be differentiated by treatment with chemical agents into distinct morphologic cell types. These differentiated cells may be of different types: (a) substrate-adherent (S), which resemble non-neuronal precursor cells; (b) a sympathoadrenal neuroblastic (N); or (c) intermediate (I), which share elements of both S and N types . Each of these cell types differs in their ability to induce a tumor. N-type cells are malignant, where as the S-type cells are not; however, the I-type cells show the greatest malignancy [10, 11]. One common neuroblastoma cell type used for in vitro research is BE(2)-M17, commonly known and henceforth called M17, which is available from ATCC.
M17 is a human neuroblastoma cell line cloned from the SK-N-Be(2) neuroblastoma cell line isolated from a 2 year old male (ATCC, Manassas, VA). M17 cells are multipotential with regard to neuronal enzyme expression e.g., choline acetyltransferase, acetylcholinesterase and dopamine-β-hydroxylase implying cholinergic, dopaminergic and adrenergic properties. M17 cells convert glutamate to GABA , however, this property is much less than that exhibited by cerebellar cortex which contains GABAergic neurons . There has been a great deal of research into differentiating the M17 cell line by treatment with trans-retinoic acid (RA); this treatment transformed the M17 cells to a morphologically distinct phenotype, i.e., neuroblastic with neuritic processes and with neurochemical characteristics [11, 14]. This treatment was the forerunner to the current clinical therapy of neuroblastomas using isotretinoin. However, little research has been performed on the functional changes in M17 cells after exposure to RA.
In the present study, we differentiated M17 cells by treatment of cultures with 10 μM RA over a time period of 72 hours and investigated the morphological, neurochemical and functional changes that occurred. We observed the formation of neuronal processes and expression of proteins (including neuron specific enolase (NSE), synaptic vesicle associated protein – 25 kDa (SNAP-25), neurofilamentin heavy chain (NF-H) and medium chain (NF-M), synapsin, and nicotinic acetylcholine receptor alpha 7 (nAchR-α7); moreover, we measured two functional parameters i.e., voltage-gated Ca2+ channel activity and stimulus-induced Ca2+-dependent neurotransmitter ([3H] glycine) release. In our and other laboratories, Ca2+-dependent [3H] glycine release inhibition due neurotoxins (e.g. botulinum neurotoxins and tetanus toxin) has been shown to be a sensitive indicator of toxicity in neuronal models such as cultured primary mouse spinal cord cells [15–17] and synaptosomes prepared from rat brain and spinal cord . We have also looked at the effects of RA differentiation on M17 cells toxicity studies of the known toxicant, phosgene (CG, COCl2). CG is a highly toxic chemical used in the manufacturing of pharmaceuticals, dyes, and polyfoam rubber products. CG causes bronchoconstriction, vasoconstriction and associated pathological effects that could be life threatening and is reported to have a neural component involved in its toxicity [19, 20].
Frozen stock of the human neuroblastoma cell line, M17 (ATCC; Gaithersburg, MD), was cultured in 75 or 150 cm2 tissue culture flasks in a 1:1 mixture of Eagle’s Minimum Essential Medium with non-essential amino acids and F12 medium containing 10% fetal bovine serum inside a humidified cell culture incubator with 95% air plus 5% carbon dioxide according to company instructions to initiate the cultures. At 70-80% confluency, the monolayer cells were sub-cultured in appropriate vessels for use in experiments. When the cultures reached about 30% confluency, these cells were differentiated by treatment with 10 μM retinoic acid (Sigma, St. Louis, MO) added to the culture medium for 2 – 3 days or until they reached the desired confluency.
Cells were grown on coverslips to approximately 80% confluency. Cell media was decanted and the cells washed in 0.1 M sodium cacodylate buffer. The cells were then fixed in buffered 1.6% formaldehyde and 2.5% glutaraldehyde for 2–3 minutes at room temperature. The fixed cells were rinsed in 0.1 M sodium cacodylate buffer and stained with methylene blue in sodium borate solution for 1–2 minutes. The stained cells were rinsed with double distilled Millipore water. The cover slips were then inverted on a 1x3 positively charged slide. The cells were viewed and photographed at a magnification of 400X with an Olympus BX61 Microscope with NIKON photo assembly Digital Site DS-L1.
M17 cells were seeded onto 18 mm coverslips coated with poly-D-lysine (Sigma Aldrich). At described times, cells were fixed for 15 min in 3.7% formaldehyde, permeabilized with 0.1% saponin in PBS and blocked with 3% BSA (PBSS). Primary antibodies against the neuron-specific proteins β3-tubulin and synapsin-1/2 (Synaptic Systems, Gottingen, Germany) were diluted 1:1000 in PBSS and applied for 1 h at room temperature, followed by Alexa-conjugated secondary antibodies (Invitrogen) diluted 1:500 in PBSS. Coverslips were mounted onto slides with Prolong Gold DAPI (Invitrogen) and imaged using a Zeiss LSM 700 confocal microscope. Z-stack images were converted to a maximum projection image using Zen 2009 (Zeiss) software.
SDS-PAGE and western blotting to assess levels of neuronal proteins
The level of neuronal proteins and SNAP-25 in M17 cells was assessed by SDS-PAGE and Western blotting following the method described by Ray et al. . Briefly, cells harvested in ice-cold physiological saline were lysed by incubating with a lysis buffer containing 10 mM Tris–HCl, 150 mM NaCl, 1 mM EDTA, 1 mg/mL BSA, 1 mM PMSF, 1% Triton X-100 and protease inhibitors present in a protease inhibitor cocktail (cat. # P8340, Sigma, St. Louis, MO) which was included throughout the wash and solubilization steps to prevent protein degradation during the assay. The lysates were cleared by centrifugation at 16,000 x g for 10 min and immediately analyzed by SDS-PAGE. Each gel (8 – 16.5% acrylamide) lane was loaded with approximately 30 μg protein, which was determined by bicinchoninic acid (BCA) protein assay. Dry transfer to polyvinylidene fluoride (PVDF) membranes was performed using the iBlot™ System (Invitrogen, Carlsbad, CA) and blocked in 2% (w/v) bovine serum albumin for 1 hr (this and all subsequent incubations were performed in physiological saline, pH 7.5, room temperature). To determine the protein levels of specific neuronal proteins, blots were probed with primary antibodies overnight at 4°C. The primary antibodies include neuron specific enolase (NSE; N6049), SNAP-25 (59682), and vimentin (V2258), all purchased from Sigma (St. Louis, MO); M1 muscarinic acetylcholine receptor (M1 mAChR, AB5164), choline acetyltransferase (ChAT, AB144P) from Cell Signaling (Boston, MA); synapsin (AB1543), neurofilament medium (145kDa, AB1981), and neurofilament heavy (200 kDa, AB1989) from Millipore (Billerica, MA); and nicotinic acetylcholine receptor α7 (nAChR-α7, ab23832, Abcam, Cambridge, MA). Antibodies to β-Actin (4967) or GAPDH (2118), both from Cell Signaling (Boston, MA), were used for normalization to confirm equivalent gel loading. This was followed by one hour incubation with a 1:1000 dilution of polyclonal peroxidase-conjugated anti-mouse IgG followed by diaminobenzidine hydrogen peroxide (H2O2) and a 1:1000 dilution of appropriate peroxidase-conjugated anti-rabbit IgG. Detection was performed by fluorescent detection of enhanced chemifluorescent (ECF) substrate (Amersham, NJ) on the Typhoon+ (GE Healthcare, Piscataway, NJ). The relative amount of protein was quantified by densitometric analysis using Image J program (NIH public domain program, (http://rsbweb.nih.gov/ij/index.html) and normalized against the respective house- keeping protein (GAPDH or β-Actin) for each parameter studied. To ensure equal loading of proteins on the gel, each marker protein was normalized against a house-keeping protein (GAPDH or β-Actin). The house-keeping protein needed to be separate from the marker protein on the gel. Differences in marker proteins in differentiated vs. undifferentiated cells were assessed in terms of % normalized optical density in differentiated cells compared to undifferentiated (no RA) controls as shown in the table. Normalized optical density of undifferentiated control was 100% for each type of marker protein.
High potassium-stimulated Ca2+-dependent neurotransmitter release was determined as previously described . Cultures were incubated with 2 μCi/mL [3H] glycine for 30 min at 37°C to label a releasable [3H] glycine pool. Cells were then washed with a series of low K+ (3 mM)-containing isotonic buffers (136 mM NaCl, 0–2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 10 mM glucose, and 0.1% BSA, ph 7.25, osmolarlity of 325 ± 5 mmol/kg). Unless otherwise indicated, [3H] glycine release was stimulated by addition of 80 mM K+ and 2 mM Ca2+ to cultures; stimulation medium was collected after 5 min at 37°C. Calcium-dependent release was determined by subtracting baseline radioactivity secreted from cultures in the absence of Ca2+, and expressed as a percentage of the total cellular radioactivity.
Radiolabeled 45Ca2+uptake due to KCl depolarization
M17 cells were seeded into 24 well plates (Corning, Lowell, MA) and cultured with 1 μCi/ml of [3H]-Valine (Perkin-Elmer, Waltham, MA) for 24 hours. The medium was then aspirated and cells were washed two times with 1 ml of a physiological balanced solution (PBS) containing in mM: 128 NaCl, 5.9 KCl, 1.28 CaCl2, 1.2 MgCl2, 17 HEPES, 3.3 glucose. All components for this solution were obtained from Sigma-Aldrich (St. Louis, MO). Cells were then incubated with an additional 1 ml aliquot of PBS for one hour for equilibration. The PBS was replaced with either PBS or stimulation medium containing 25 – 100 mM KCl and 1 μCi/ml 45CaCl2. The different KCl concentrations were adjusted by reducing the NaCl concentration proportionately to maintain iso osmolality. The addition of 1 μCi/ml of 45CaCl2 did not significantly alter the osmolality or the concentration of CaCl2 (data not shown). After 4 minutes, the radioactive medium was aspirated and ice-cold PBS was used to wash cells twice. The cells were then lyzed by adding 0.4 N NaOH solution and rocked overnight at 4°C. The next day, the 0.4N NaOH solution was pH neutralized with 0.4N HCl + Tris. The neutralized solution was added to scintillation fluid and 45Ca and 3H levels were measured on a Beckman LS6500 multi-purpose scintillation counter (Beckman-Coulter, Brea, CA). Calcium-dependent release was determined by subtracting baseline radioactivity secreted from cultures in the absence of Ca2+, and expressed as a percentage of the total cellular radioactivity. Total cellular radioactivity was calculated by adding the 45Ca2+ cpm released upon stimulation with high KCl and the 45Ca2+ cpm present in the resting medium with low KCl before and after stimulation.
Direct Ca2+uptake assay (Fluo-4 Direct™ assay kit)
The Ca2+ uptake assay kit (Fluo-4 Direct™, Invitrogen, Carlsbad, California) contains a fluo-4 analog that produces a large fluorescence intensity increase in response to Ca2+ binding with fluorescence excitation at 495 nm and emission at 516 nm. The Fluo-4™ Direct Ca2+ Assay kit was used according to the manufacturer’s instructions. Briefly, 2X Fluo-4 Direct Ca2+ assay buffer (1M HEPES in Hanks buffered saline solution, pH 7.3) was thawed and mixed with 5 mM probenecid. The assay was conducted in monolayer cultures. The 2X Fluo-4 Direct Ca2+ assay buffer with 5 mM probenecid was added in equal volume to the sample volume and incubated at 37°C for approximately one hour (Fluo-4 loading of cells). The fluorescence (absolute units) was measured using the SpectraMax Gemini EM (MDS Analytical Technologies, Toronto, Canada) using excitation and emission wavelengths mentioned above.
Phosgene (CG) exposure
CULTEX air/liquid exposure system for either 12 mm or 24 mm culture filters was purchased from VetroCell (Germany). Prior to exposure to CG, the cells grown on these filters were transferred into the exposure device. Cells were nourished by culture growth medium below the filter membrane and exposed directly to either air (unexposed control samples) or air/CG (experimental samples) without growth medium on top of the cells. The vapor exposure system was moved to a chemical agent exposure hood and exposed to CG by connecting to the inlet of the CULTEX system that ends on a hyperboloid-shaped air distribution (trumpet) ensuring uniform exposure of the aerosol on the surface of the cell culture [23–27]. The outlet of the exposure system was passed through a decontamination solution. After exposure to air or CG, the cells were fed with fresh medium from the upper side and free intracellular Ca2+ was monitored by the Fluo-4 Direct Assay described above.
To assess intracellular free Ca2+ changes due to CG exposure, undifferentiated or differentiated M17 cells were first loaded with Fluo-4 and an initial fluorescence reading was taken to record the basal Ca2+ level (i.e., the resting intracellular Ca2+ levels without any treatment). The cells were then exposed to either 0 ppm (air) or 16 ppm of CG (in air) for 8 min at a flow rate of 8.13 ml/well/min. The free intracellular Ca2+ changes were monitored directly following exposure as a function of time.
Treatment with Ca2+ionophore A23187
The Ca2+ Ionophore A23187 (Invitrogen, Carlsbad, California) was prepared at stock concentration in DMSO according to manufacturer’s instructions. Further dilutions were prepared in M17 medium. A23187 was added directly to M17 cells cultured in transwell inserts to obtained final concentration of 5 μM. To assess intracellular free Ca2+, the cells were first loaded with Fluo-4 prior to addition of A23187 and the change in intracellular Ca2+ concentration was measured directly following addition of A23187 using Fluo-4 Direct Assay.
Morphological changes and possible synaptic activity
Expression of neuron specific proteins
Expression of functional voltage-gated Ca 2+channels
Differentiated M17 cells as a model to study neurotoxicity
Neuronal cell models have been tested for their use in predicting in vivo effects of different neurotoxic substances [1, 2, 4, 5]. Attempts have been made to develop and to utilize these in vitro neuronal models to study the mechanisms of toxicity due to chemical and biological compounds at cellular and molecular levels. Moreover, these models have also been tested for their use in rapid screening of potential neurotoxicants out of which positive compounds would be selected for in vivo evaluation. Prior studies using in vitro cellular models were intended to generate preliminary mechanistic and toxicity information while reducing animal use and associated high cost of in vivo testing. The following are the three different types of in vitro cellular models primarily used in biomedical research; (1) primary cell cultures, (2) clonal cell lines, and (3) neural stem cells. The main advantage of using primary cell cultures is that they retain the morphological, neurochemical, and electrophysiological properties of neurons in situ. However, the disadvantages of primary cell cultures include (a) a limited life span, (b) increased genetic variability between model systems and cultures, (c) mixture of different neuronal populations in each preparation, as well as (d) high resource requirements . Neural stem cells have the ability for self renewal and generating multiple cell types representing different parts of the nervous system; moreover, they can be derived from humans. However, as with primary cultures, the stem cells require animal use resulting in high resource requirements and regulatory issues. After neural stem cells have reached the end of their short variable life span, a new line has to be generated and then characterized before use [2, 32]; this is neither time nor cost effective.
A clonal cell line is defined as a population of cells that originated from a single source and can be maintained in culture for an extended period of time. A clonal cell culture has a number of advantages that make them useful as in vitro models: easy to obtain; relatively easy to grow; divide rapidly; and can be continuously subcultured for a relatively high number of passages to provide a large number of cells in a short period of time . The clonal M17 neuroblastoma cell line used in this study has the characteristics described above as well as the ability to become differentiated into a neuroblastic (N) cell when cultured in the presence of RA for several days [11, 14]. These properties make the M17 cell line a good in vitro cell model for mechanistic and neurotoxicity testing. However, the functional changes in M17 cells due to RA differentiation have not been thoroughly characterized. A very relevant question is why do we need a differentiated neuronal model for neurobiology studies. The answer is that most of the neuronal functions such as membrane excitability, ion channels, neurotransmitter release, endocyctotic and exocyctotic events etc. are characteristics of mature neurons and cannot be studied in an immature neuronal model.
Treatment with RA results in the progressive development of neuronal morphologies and formation of neuronal networks seen in a more mature neuronal culture over time. A commonly measured characteristic of differentiation is extension of neurites that are akin to the axons and dendrites of fully differentiated neurons . These neuronal properties in RA differentiated M17 cells were evidenced by both light microscopic observations (Figure 1) and immunofluorescence staining (Figure 2B - D). Although differentiated M17 cells demonstrated evidence of maturing neuronal organization and properties, the functional verification of synaptic activity remains to be done.
Besides morphological characteristics, we also observed differences in expression of several neuron specific proteins between undifferentiated and differentiated M17 cells (Figure 4). The presence or levels of certain proteins can vary between immature and mature neurons. One such protein is neuron specific enolase (NSE) which is responsible for generating phosphopyruvate hydratase that participates in glycolosis/gluconeogenesis; the levels of NSE increase as the neurons mature. While undifferentiated M17 cells do express NSE, its level increases due to differentiation. The formation of neurite-like processes as a part of synaptic organization and activity can be further characterized with the differential expression of the neurofilament proteins, NF-M, and –H that help form the neurofibrils within axons . Developing neurons generally do not express either of these neurofilament proteins until they become post-mitotic, which is fairly late in development. Another neurofilament subunit, vimentin, decreases as neurons mature . We were able to detect vimentin (Figure 4C) and the neurofilament proteins -M as well as -H (data not shown). We observed a decreased level of vimentin, whereas neurofilaments H and M increased due to differentiation. This might be an indication that under the conditions used, M17 cells could be in an early stage of maturation. This hypothesis is supported by the wide-spread expression of the immature neuronal marker β3-tubulin and the accumulation of synapsin-1/2 at the tip of the growth cone (Figure 3). The presence of synapsin within the growth cone is consistent with studies suggesting an axonogenic role during neurite extension and branching, which is a early aspect of neuronal maturation [35, 36]. The levels and localization of these developmentally staged proteins are anticipated to further change during prolonged culture in the presence of RA.
Since M17 cells are multipotential with regard to neuronal enzyme expression, we looked at the effects of RA differentiation on the expression of the main isoforms of acetylcholine (ACh) receptors (M1 mAChR, nAChR – α7) and choline acetyltransferase (ChAT) to determine the type of neurons that RA differentiated M17 cells could be. In Figure 5, nAChR-α7 was the only one of the mentioned proteins that was able to be detected. This indicates that the RA differentiated M17 cells are not cholinergic but would most likely be involved in post- and pre-synaptic excitation in the brain and not post-ganglion nerves in the CNS or exocrine glands [37, 38].
The differential expression of other neuronal proteins than those previously described, expression of voltage-gated Ca2+ channels and ionotropic receptors, which ultimately lead to an increase in neurotransmitter release, can be used to confirm neuronal characteristics and neuroexocytosis. The presence of SNAP-25 and synapsin are indicative of the potential to form functioning pre-synaptic compartments that mediate synaptic vesicle fusion with the pre-synaptic membrane and neurotransmitter release under depolarizing conditions. Although immunoblot demonstrated that overall synapsin expression in M17 cells does not significantly change after differentiation with RA (Figure 4B), synapsin-1/2 becomes distributed along processes, with a punctuate appearance (Figure 2 and supporting Additional file 1: Figure S1) and within the growth cone during neuritogenesis (Figure 3). SNAP-25 is a major component of the SNARE complex that is required for the fusion of vesicle to the cell membrane for the exocytosis of neurotransmitters. A two fold increase in the level of SNAP-25 (Figure 4A) was observed. This increase in SNAP-25 level may correlate with the significant (p<0.01) increase in KCl stimulated [3H] glycine release seen in differentiated M17 cells (Figure 6). The increase in the stimulated release as shown in Figure 6 doesn’t look impressive; however, it is quite marked because we are comparing the fraction of the total pool of [3H] glycine that is released in differentiated cells vs. undifferentiated cells. As mentioned earlier, we studied [3H] glycine release because this assay has been utilized successfully in assessment of neurotoxicity in cell culture models [15–18]. Others have studied glutamate release and glutamate induced excitotoxicity in M17 cells  and as such these cells could be suitable to study glutamate neurotoxicity. Since M17 cells have been reported to have a poor GABAergic property  these cells might not be a suitable model for GABA studies. In this report we demonstrated that a representative neurotransmitter function is enhanced in differentiated M17 cells compared to immature cells.
For functional neuroexocytosis, neurons need both the ability to form the SNARE complex and to have functional voltage-gated Ca2+ channels. The ability of Ca2+ and other ions to move across the cell membrane is necessary for excitation and signal transmission between neurons. Therefore, we studied the uptake of Ca2+ in both undifferentiated and differentiated M17 cells. There was no increase in the uptake of radiolabeled 45Ca2+ using varying concentrations of KCl in undifferentiated M17 cells (Figure 7A); a strong increase in the uptake of radiolabeled 45Ca2+ was observed with RA differentiation of M17 cells with a maximum opening of voltage-gated Ca2+ channels at 25 mM KCl. The presence of both N and P/Q type Ca2+ channels was indicated by the 50 – 60% reduction in Ca2+ uptake when conotoxin GVIA (N-type blocker) (Figure 7D) or agatoxin IVA (P/Q blocker) (Figure 7E) were applied to the culture. Using NNC 55–0396, only a small amount of T-type Ca2+ channels were detected (Figure 7C); however, the assay may not be sensitive enough to pick up the small change in intracellular Ca2+ concentration due to the small unitary conductance of T-type Ca2+ channels. Since neuroexocytosis is Ca2+ dependent, the lack of functional voltage-gated Ca2+ channels in undifferentiated M17 cells is detrimental for its use as a cell model for neurotoxicity research. The treatment of M17 with RA for a minimum of 72 hrs may be essential for functional neuronal cultures. It has been postulated that neuronal functions are cell maturation dependent .
In toxicity studies, it is important to look at both morphological and functional changes to determine toxicological mechanisms. It has been shown here as well as in other studies that maturation of neuronal cultures is very important when studying the effects of toxicants . It is known that intracellular Ca2+ is highly regulated and involved in normal cell functions and in toxicological mechanisms. The lack of voltage-gated Ca2+ channel expression in undifferentiated M17 cells could limit their use as a neurotoxicity model. This is supported by our observation that differentiation of M17 cells with RA was required to see the changes in [Ca2+]i following exposure to CG. The [Ca2+]i decrease due to CG is a toxicant response in neuronal cells that can lead to apoptosis and death of neurons [39, 40]. Acquisition in voltage-gated Ca2+ channels in differentiated neurons may be a prerequisite for studying neurotoxicity due to chemicals other than CG.
The results reported here show that the human neuroblastoma BE(2)-M17 cells need to be treated with RA to become differentiated into mature neurons and to exhibit functional neuroexocytosis. Differentiation with RA induces M17 cells to undergo morphological differentiation and synaptic maturation. The apparent formation of neural networks, the presence and function of SNARE proteins and voltage-gated Ca2+ channels are necessary for functional neuroexocytosis. Our results showing the presence of these characteristics supports the use of differentiated M17 cells as a cell model for neurobiology and/or neurotoxicity research.
BE(2)-M17 cell line
Neuron specific enolase
Synaptosomal-associated protein 25
Nicotinic acetylcholine receptor α7
Neurofilamentin heavy chain
Neurofilamentin medium chain
Neurofilamentin light chain
0.1% saponin in PBS and blocked with 3% BSA
- M1 mAChR:
M1 muscarinic acetylcholine receptor
Intracellular free Ca2+ concentration
Central nervous system
Soluble NSF attachment protein receptor.
This research was supported by the Defense Threat Reduction Agency – Joint Science and Technology Office, Medical S&T Division, an interagency agreement between NIH/NIAID (Y1-A1-6179-04) and the USAMRICD (A120-B.P2009-03) and in part by an appointment to the Postgraduate Research Participation Program at the U.S. Army Medical Research Institute of Chemical Defense administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and U.S. Army Medical Research and Materiel Command (USAMRMC). We acknowledge Dr. Heidi Hoard-Fruchey for giving us the antibodies for our studies on the cholinergic properties and Dr. Dorian Olivera for helping us with phosgene exposure of cells. We also acknowledge Drs. Shane Kasten and Brian Molles for their careful reviews of the manuscript and comments.
The views expressed in this article are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government.
- Harry GJ, Billingsley M, Bruinink A, Campbell IL, Classen W, Dorman DC, Galli C, Ray D, Smith RA, Tilson HA: In vitro techniques for the assessment of neurotoxicity. Environ Health Perspect. 1998, 106 (Suppl 1): 131-158. 10.1289/ehp.98106s1131.PubMed CentralView ArticlePubMedGoogle Scholar
- Radio NM, Mundy WR: Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology. 2008, 29 (3): 361-376. 10.1016/j.neuro.2008.02.011.View ArticlePubMedGoogle Scholar
- Tiffany-Castiglioni E, Ehrich M, Dees L, Costa LG, Kodavanti PR, Lasley SM, Oortgiesen M, Durham HD: Bridging the gap between in vitro and in vivo models for neurotoxicology. Toxicol Sci. 1999, 51 (2): 178-183. 10.1093/toxsci/51.2.178.View ArticlePubMedGoogle Scholar
- Tiffany-Castiglioni E, Hong S, Qian Y, Tang Y, Donnelly KC: In vitro models for assessing neurotoxicity of mixtures. Neurotoxicology. 2006, 27 (5): 835-839. 10.1016/j.neuro.2006.05.010.View ArticlePubMedGoogle Scholar
- Cho T, Tiffany-Castiglioni E: Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells. J Toxicol Environ Health A. 2004, 67 (13): 987-1000. 10.1080/15287390490447287.View ArticlePubMedGoogle Scholar
- Ray J, Peterson DA, Schinstine M, Gage FH: Proliferation, differentiation, and long-term culture of primary hippocampal neurons. Proc Natl Acad Sci U S A. 1993, 90 (8): 3602-3606. 10.1073/pnas.90.8.3602.PubMed CentralView ArticlePubMedGoogle Scholar
- Costa LG: Neurotoxicity testing: a discussion of in vitro alternatives. Environ Health Perspect. 1998, 106 (Suppl 2): 505-510. 10.1289/ehp.98106505.PubMed CentralView ArticlePubMedGoogle Scholar
- Gartlon J, Kinsner A, Bal-Price A, Coecke S, Clothier RH: Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicol In Vitro. 2006, 20 (8): 1569-1581. 10.1016/j.tiv.2006.07.009.View ArticlePubMedGoogle Scholar
- Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, Cheung NK, Ross RA: Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia. 2004, 6 (6): 838-845. 10.1593/neo.04310.PubMed CentralView ArticlePubMedGoogle Scholar
- Messi E, Florian MC, Caccia C, Zanisi M, Maggi R: Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression. BMC Cancer. 2008, 8: 30-10.1186/1471-2407-8-30.PubMed CentralView ArticlePubMedGoogle Scholar
- Ross RA, Biedler JL, Spengler BA: A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors. Cancer Lett. 2003, 197 (1–2): 35-39.View ArticlePubMedGoogle Scholar
- Bjarnadottir M, Misner DL, Haverfield-Gross S, Bruun S, Helgason VG, Stefansson H, Sigmundsson A, Firth DR, Nielsen B, Stefansdottir R: Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/− knock-outs compared with wild-type mice. J Neurosci. 2007, 27 (17): 4519-4529. 10.1523/JNEUROSCI.4314-06.2007.View ArticlePubMedGoogle Scholar
- Biedler JL, Helson L, Spengler BA: Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973, 33 (11): 2643-2652.PubMedGoogle Scholar
- Melino G, Thiele CJ, Knight RA, Piacentini M: Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol. 1997, 31 (1–2): 65-83.View ArticlePubMedGoogle Scholar
- Keller JE, Neale EA: The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A. J Biol Chem. 2001, 276 (16): 13476-13482. 10.1074/jbc.M010992200.View ArticlePubMedGoogle Scholar
- Sheridan RE, Smith TJ, Adler M: Primary cell culture for evaluation of botulinum neurotoxin antagonists. Toxicon. 2005, 45 (3): 377-382. 10.1016/j.toxicon.2004.11.009.View ArticlePubMedGoogle Scholar
- Ray R, Zhang P, Ray P: Neuronal functions associated with endo- and exocytotic events-cum-molecular trafficking may be cell maturation-dependent: lessons learned from studies on botulism. Cell Mol Neurobiol. 2011, 31 (6): 861-865. 10.1007/s10571-011-9678-1.View ArticlePubMedGoogle Scholar
- Bigalke H, Heller I, Bizzini B, Habermann E: Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn Schmiedebergs Arch Pharmacol. 1981, 316 (3): 244-251. 10.1007/BF00505657.View ArticlePubMedGoogle Scholar
- Anand A, Paintal AS, Whitteridge D: Mechanisms underlying enhanced responses of J receptors of cats to excitants in pulmonary oedema. J Physiol. 1993, 471: 535-547.PubMed CentralView ArticlePubMedGoogle Scholar
- Sciuto AM, Lee RB, Forster JS, Cascio MB, Clapp DL, Moran TS: Temporal changes in respiratory dynamics in mice exposed to phosgene. Inhal Toxicol. 2002, 14 (5): 487-501. 10.1080/089583701753678580.View ArticlePubMedGoogle Scholar
- Ray P, Millard CB, Petrali JP, Berman JD, Ray R: Acetylcholine exocytosis in PC12 cells deficient in SNAP-25. Neuroreport. 1997, 8 (9–10): 2271-2274.View ArticlePubMedGoogle Scholar
- Williamson LC, Halpern JL, Montecucco C, Brown JE, Neale EA: Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J Biol Chem. 1996, 271 (13): 7694-7699. 10.1074/jbc.271.13.7694.View ArticlePubMedGoogle Scholar
- Aufderheide M: Direct exposure methods for testing native atmospheres. Exp Toxicol Pathol. 2005, 57 (Suppl 1): 213-226.View ArticlePubMedGoogle Scholar
- Aufderheide M, Knebel JW, Ritter D: A method for the in vitro exposure of human cells to environmental and complex gaseous mixtures: application to various types of atmosphere. Altern Lab Anim. 2002, 30 (4): 433-441.PubMedGoogle Scholar
- Aufderheide M, Knebel JW, Ritter D: An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Exp Toxicol Pathol. 2003, 55 (1): 51-57. 10.1078/0940-2993-00298.View ArticlePubMedGoogle Scholar
- Aufderheide M, Knebel JW, Ritter D: Novel approaches for studying pulmonary toxicity in vitro. Toxicol Lett. 2003, 140–141: 205-211.View ArticlePubMedGoogle Scholar
- Aufderheide M, Mohr U: CULTEX–an alternative technique for cultivation and exposure of cells of the respiratory tract to airborne pollutants at the air/liquid interface. Exp Toxicol Pathol. 2000, 52 (3): 265-270. 10.1016/S0940-2993(00)80044-5.View ArticlePubMedGoogle Scholar
- Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC: Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res. 1993, 53 (20): 4978-4986.PubMedGoogle Scholar
- Herrero CJ, Garcia-Palomero E, Pintado AJ, Garcia AG, Montiel C: Differential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem. Br J Pharmacol. 1999, 127 (6): 1375-1387. 10.1038/sj.bjp.0702692.PubMed CentralView ArticlePubMedGoogle Scholar
- Huang L, Keyser BM, Tagmose TM, Hansen JB, Taylor JT, Zhuang H, Zhang M, Ragsdale DS, Li M: NNC 55–0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluo ro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther. 2004, 309 (1): 193-199. 10.1124/jpet.103.060814.View ArticlePubMedGoogle Scholar
- Turner TJ, Adams ME, Dunlap K: Calcium channels coupled to glutamate release identified by omega-Aga-IVA. Science. 1992, 258 (5080): 310-313. 10.1126/science.1357749.View ArticlePubMedGoogle Scholar
- Varga BV, Hadinger N, Gocza E, Dulberg V, Demeter K, Madarasz E, Herberth B: Generation of diverse neuronal subtypes in cloned populations of stem-like cells. BMC Dev Biol. 2008, 8: 89-10.1186/1471-213X-8-89.PubMed CentralView ArticlePubMedGoogle Scholar
- Abemayor E, Sidell N: Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ Health Perspect. 1989, 80: 3-15.PubMed CentralView ArticlePubMedGoogle Scholar
- Shaw G: Neurofilament proteins. The Neuronal Cytoskeleton. Edited by: Burgoyne R. 1991, New York: Wiley-Liss, 195-214.Google Scholar
- Chin LS, Li L, Ferreira A, Kosik KS, Greengard P: Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice. Proc Natl Acad Sci U S A. 1995, 92 (20): 9230-9234. 10.1073/pnas.92.20.9230.PubMed CentralView ArticlePubMedGoogle Scholar
- Tojima T, Akiyama H, Itofusa R, Li Y, Katayama H, Miyawaki A, Kamiguchi H: Attractive axon guidance involves asymmetric membrane transport and exocytosis in the growth cone. Nat Neurosci. 2007, 10 (1): 58-66. 10.1038/nn1814.View ArticlePubMedGoogle Scholar
- Blankenship J: Neurophysiology. 2003, St Louis: MosbyGoogle Scholar
- Squire LR BF, McConnell SK, Roberts JL, Spitzer NC, Zigmond MJ: Fundamental neuroscience. 2003, Amsterdam: Academic Press, 2Google Scholar
- Turner CP, Connell J, Blackstone K, Ringler SL: Loss of calcium and increased apoptosis within the same neuron. Brain Res. 2007, 1128 (1): 50-60.PubMed CentralView ArticlePubMedGoogle Scholar
- Turner CP, Pulciani D, Rivkees SA: Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol. 2002, 178 (1): 21-32. 10.1006/exnr.2002.8027.View ArticlePubMedGoogle Scholar